Entity Details

Primary name MUSK_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionO15146
EntryNameMUSK_HUMAN
FullNameMuscle, skeletal receptor tyrosine-protein kinase
TaxID9606
Evidenceevidence at protein level
Length869
SequenceStatuscomplete
DateCreated2004-07-19
DateModified2021-06-02

Ontological Relatives

GenesMUSK

GO terms

Show/Hide Table
GOName
GO:0001934 positive regulation of protein phosphorylation
GO:0004713 protein tyrosine kinase activity
GO:0004714 transmembrane receptor protein tyrosine kinase activity
GO:0005518 collagen binding
GO:0005524 ATP binding
GO:0005887 integral component of plasma membrane
GO:0007169 transmembrane receptor protein tyrosine kinase signaling pathway
GO:0007275 multicellular organism development
GO:0007528 neuromuscular junction development
GO:0007613 memory
GO:0008582 regulation of synaptic assembly at neuromuscular junction
GO:0010628 positive regulation of gene expression
GO:0030154 cell differentiation
GO:0031594 neuromuscular junction
GO:0033674 positive regulation of kinase activity
GO:0038062 protein tyrosine kinase collagen receptor activity
GO:0043235 receptor complex
GO:0045211 postsynaptic membrane
GO:0046777 protein autophosphorylation
GO:0046872 metal ion binding
GO:0071340 skeletal muscle acetylcholine-gated channel clustering
GO:2000541 positive regulation of protein geranylgeranylation

Subcellular Location

Show/Hide Table
Subcellular Location
Cell junction

Domains

Show/Hide Table
DomainNameCategoryType
IPR000719 Protein kinase domainDomainDomain
IPR001245 Serine-threonine/tyrosine-protein kinase, catalytic domainDomainDomain
IPR003598 Immunoglobulin subtype 2DomainDomain
IPR003599 Immunoglobulin subtypeDomainDomain
IPR007110 Immunoglobulin-like domainDomainDomain
IPR008266 Tyrosine-protein kinase, active siteSiteActive site
IPR011009 Protein kinase-like domain superfamilyFamilyHomologous superfamily
IPR013098 Immunoglobulin I-setDomainDomain
IPR013783 Immunoglobulin-like foldFamilyHomologous superfamily
IPR017441 Protein kinase, ATP binding siteSiteBinding site
IPR020067 Frizzled domainDomainDomain
IPR020635 Tyrosine-protein kinase, catalytic domainDomainDomain
IPR036179 Immunoglobulin-like domain superfamilyFamilyHomologous superfamily
IPR036790 Frizzled cysteine-rich domain superfamilyFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
208150 OMIMFetal akinesia deformation sequence 1 (FADS1)A clinically and genetically heterogeneous group of disorders with congenital malformations related to impaired fetal movement. Clinical features include fetal akinesia, intrauterine growth retardation, polyhydramnios, arthrogryposis, pulmonary hypoplasia, craniofacial abnormalities, and cryptorchidism. FADS1 inheritance is autosomal recessive. The disease is caused by variants affecting the gene represented in this entry.
616325 OMIMMyasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency (CMS9)A form of congenital myasthenic syndrome, a group of disorders characterized by failure of neuromuscular transmission, including pre-synaptic, synaptic, and post-synaptic disorders that are not of autoimmune origin. Clinical features are easy fatigability and muscle weakness affecting the axial and limb muscles (with hypotonia in early-onset forms), the ocular muscles (leading to ptosis and ophthalmoplegia), and the facial and bulbar musculature (affecting sucking and swallowing, and leading to dysphonia). The symptoms fluctuate and worsen with physical effort. CMS9 is a disorder of postsynaptic neuromuscular transmission, due to deficiency of AChR at the endplate that results in low amplitude of the miniature endplate potential and current. The disease is caused by variants affecting the gene represented in this entry. MUSK mutations lead to decreased agrin-dependent AChR aggregation, a critical step in the formation of the neuromuscular junction.

Drugs

Show/Hide Table
DrugNameSourceType
DB12010 FostamatinibDrugbanksmall molecule